Glutamine metabolism in cancer therapy

Abstract

The amino acid glutamine plays a key role in the metabolism of highly proliferating cells. During malignant transformation, cancer cells modify the consumption and processing of glutamine to sustain cell growth and proliferation. In some cases, these cancer cells become addicted to glutamine. Thus, targeting the metabolism of glutamine has been developed during last years as a potential strategy against cancer. In this review, we summarized the last advances in our knowledge about the role of glutamine metabolism in cancer therapy.

Keywords

Cancer / glutamine / glutamoptosis / metabolism / mammalian target of rapamycin

References

[1] Hanahan D.Hallmarks of cancer: the next generation.Cell2011;144:646-74

[2] Warburg O.On the origin of cancer cells.Science1956;123:309-14

[3] Vander Heiden MG,Thompson CB.Understanding the warburg effect: the metabolic requirements of cell proliferation.Science2009;324:1029-33 PMCID:PMC2849637

[4] Almuhaideb A,Bomanji J.18F-FDG PET/CT imaging in oncology.Ann Saudi Med2011;31:3-13 PMCID:PMC3101722

[5] Barthel A,Liao J,Li J,Roth RA.Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1.J Biol Chem1999;274:20281-6

[6] Wieman HL,Rathmell JC.Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking.Mol Biol Cell2007;18:1437-46 PMCID:PMC1838986

[7] Deprez J,Alessi DR,Rider MH.Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades.J Biol Chem1997;272:17269-75

[8] Gottlob K,Kennedy S,Robey RB.Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase.Genes Dev2001;15:1406-18 PMCID:PMC312709

[9] Lee JH,Li J,Wang Y,Qian X,Zheng Y,Chen Q,Jiang T.Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis.Nat Commun2017;8:949 PMCID:PMC5643558

[10] Murakami T,Shirotani T,Kan M,Kanai F,Ebina Y.Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes.J Biol Chem1992;267:9300-6

[11] Eagle H.The minimum vitamin requirements of the L and HeLa cells in tissue culture, the production of specific vitamin deficiencies, and their cure.J Exp Med1955;102:595-600 PMCID:PMC2136536

[12] Nicklin P,Zhang B,Wang H,Yang H,Kung C,Myer VE,Porter JA,Cantley LC,Murphy LO.Bidirectional transport of amino acids regulates mTOR and autophagy.Cell2009;136:521-34 PMCID:PMC3733119

[13] Kaira K,Imai H,Yanagitani N,Hisada T,Ishizuka T,Endou H,Mori M.Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer.Br J Cancer2008;98:742-8 PMCID:PMC2259171

[14] Sakata T,Tsuruta T,Baba S,Ueno A,Endou H.L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer.Pathol Int2009;59:7-18

[15] Lieberman BP,Wang L,Zha Z,Chodosh LA,Thompson CB.PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.J Nucl Med2011;52:1947-55

[16] Venneti S,Zhang H,Zanzonico P,Carlin SD,Lyashchenko S,Rohle D,Cross JR,Weber WA,Mellinghoff IK,Lewis JS.Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.Sci Transl Med2015;7:274ra17

[17] Wang R,Shi LZ,Carter R,McCormick LL,Chi H,Green DR.The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.Immunity2011;35:871-82 PMCID:PMC3248798

[18] Wise DR,Mancuso A,Zhang XY,Nissim I,Yudkoff M,Thompson CB.Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.Proc Natl Acad Sci2008;105:18782-7 PMCID:PMC2596212

[19] Eberhardy SR.c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism.J Biol Chem2001;276:48562-71

[20] Gao P,Chang TC,Kita K,Zeller KI,Van Eyk JE,Dang CV.c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.Nature2009;458:762-5 PMCID:PMC2729443

[21] Mannava S,Wheeler LJ,Zhuang D,Mathews CK,Nikiforov MA.Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells.Cell Cycle2008;7:2392-400 PMCID:PMC3744895

[22] Reynolds MR,Robertson B,Liu Y,Dean DC.Control of glutamine metabolism by the tumor suppressor Rb.Oncogene2014;33:556-66 PMCID:PMC3918885

[23] Kuo W,Tang TK.Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice.Int J cancer2000;85:857-64

[24] Wang C,Gao D,Jiang K,Sun L,Sun C,Wu W,Liu Y.Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples.Cancer Lett2011;313:154-66

[25] Locasale JW,Melman T,Mattaini KR,Heffron G,Muranen T,Sasaki AT,Mullarky E,Sasaki M,Stephanopoulos G,Meyerson M,Chin L,Asara JM,Cantley LC.Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis.Nat Genet2011;43:869-74 PMCID:PMC3677549

[26] Possemato R,Shaul YD,Kim D,Sethumadhavan S,Jang HG,Chen WW,Stransky N,Cowley GS,Kalaany NY,Ottina K,Yuan B,Root DE,Brachtel EF,Sabatini DM.Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.Nature2011;476:346-50 PMCID:PMC3353325

[27] Bauer DE,Zhao F,Thompson CB.ATP citrate lyase is an important component of cell growth and transformation.Oncogene2005;24:6314-22

[28] Hatzivassiliou G,Bauer DE,Shaw AN,Hingorani SR,Thompson CB.ATP citrate lyase inhibition can suppress tumor cell growth.Cancer Cell2005;8:311-21

[29] Berwick DC,Heesom KJ,Tavare JM.The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes.J Biol Chem2002;277:33895-900

[30] Birsoy K,Chen WW,Abu-Remaileh M.An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis.Cell2015;162:540-51 PMCID:PMC4522279

[31] Sullivan LB,Hosios AM,Freinkman E.Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells.Cell2015;162:552-63 PMCID:PMC4522278

[32] DeBerardinis RJ,Daikhin E,Yudkoff M,Thompson CB.Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.Proc Natl Acad Sci U S A2007;104:19345-50 PMCID:PMC2148292

[33] Yuneva M,Oefner P,Lazebnik Y.Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells.J Cell Biol2007;178:93-105 PMCID:PMC2064426

[34] Metallo CM,Bell EL,Yang J,Jewell CM,Irvine DJ,Kelleher JK,Iliopoulos O.Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia.Nature2011;481:380-4 PMCID:PMC3710581

[35] Brosnan JT.Interorgan amino acid transport and its regulation.J Nutr2003;133:2068S-72S

[36] Wang JB,Fuji R,Gao P,Wilson KF,Dias SM,Cerione RA.Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.Cancer Cell2010;18:207-19 PMCID:PMC3078749

[37] Krebs HA.Metabolism of amino-acids: the synthesis of glutamine from glutamic acid and ammonia, and the enzymic hydrolysis of glutamine in animal tissues.Biochem J1935;29:1951-69 PMCID:PMC1266709

[38] Yielding KL.An effect of L-leucine and other essential amino acids on the structure and activity of glutamic dehydrogenase.Proc Natl Acad Sci U S A1961;47:983-9

[39] Long J,Wang HG,Wang BE.Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.Hepatobiliary Pancreat Dis Int2010;9:296-305

[40] Rosati A,Todeschini A,Medicina D,Simoncini EL,Buglione M,Padovani A.Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme.Neuro Oncol2013;15:618-25 PMCID:PMC3635515

[41] Gameiro PA,Metelo AM,Baker R,Arreola A,Olumi A,Stephanopoulos G.In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation.Cell Metab2013;17:372-85 PMCID:PMC4003458

[42] Jiang L,Swain P,Parker SJ,Terada LS,McCabe MT,Schmidt S,Dranka BP,DeBerardinis RJ.Reductive carboxylation supports redox homeostasis during anchorage-independent growth.Nature2016;532:255-8 PMCID:PMC4860952

[43] Mullen AR,Jin ES,Sullivan LB,Yang Y,Chandel NS.Reductive carboxylation supports growth in tumour cells with defective mitochondria.Nature2011;481:385-8 PMCID:PMC3262117

[44] Patel D,Bernfeld E,Kalan S,Foster DA.Aspartate rescues S-phase arrest caused by suppression of glutamine utilization in KRas-driven cancer cells.J Biol Chem2016;291:9322-9 PMCID:PMC4861495

[45] Zhang J,Venneti S,Takagi T,Djaballah H,Cheng EH,Pawel B,Cherry S,Thompson CB.Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion.Mol Cell2014;56:205-18 PMCID:PMC4224619

[46] Hao Y,Li Q,Guan BJ,Jin Z,Cao B,Xiang M,Fink S,Xu Y,Markowitz S,Velculescu VE,Willis JE,Hatzoglou M,Vogelstein B.Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer.Nat Commun2016;7:11971 PMCID:PMC4915131

[47] Xu P,Stein S,Ryu D,Wang X,Zamboni N,Auwerx J.LRH-1-dependent programming of mitochondrial glutamine processing drives liver cancer.Genes Dev2016;30:1255-60 PMCID:PMC4911925

[48] Vié N,Bascoul-Mollevi C,Bec N,Fraslon C,Molina F,Martineau P,Gongora C.Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells.Mol Cancer2008;7:14 PMCID:PMC2245978

[49] Liu W,Hancock C,Dang CV,Phang JM.Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC.Proc Natl Acad Sci U S A2012;109:8983-8 PMCID:PMC3384197

[50] Li H,Bazer FW.Intracellular sources of ornithine for polyamine synthesis in endothelial cells.Amino Acids2016;48:2401-10

[51] Altman BJ,Dang CV.From Krebs to clinic: glutamine metabolism to cancer therapy.Nat Rev Cancer2016;16:619-34 PMCID:PMC5484415

[52] Hosios AM,Danai LV,Rathmell JC,Manalis SR.Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells.Dev Cell2016;36:540-9 PMCID:PMC4766004

[53] Xiang L,Liu C,Chen J,Li J,Shi H.Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation.Biochim Biophys Acta2013;1833:2996-3005

[54] Timmerman LA,Yuneva M,Padró M,Hu M,Ethier SP,Polyak K,Gray JW.Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target.Cancer Cell2013;24:450-65 PMCID:PMC3931310

[55] Tsuchihashi K,Ohmura M,Sampetrean O,Wakimoto H,Seishima R,Morikawa T,Takao A,Masuko T,Furnari FB,Suematsu M,Akashi K,Nagano O.The EGF receptor promotes the malignant potential of glioma by regulating amino acid transport system xc(-).Cancer Res2016;76:2954-63 PMCID:PMC4873328

[56] Koppula P,Shi J,Gan B.The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.J Biol Chem2017;292:14240-9 PMCID:PMC5572906

[57] Sayin VI,Singh SX,Biancur D,Alvarez SW,Karakousi TR,Ubriaco J,Karagiannis D,Thomas CJ,Vander Heiden MG.Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer.Elife2017;

[58] Shin CS,Watrous JD,D'Aurelio M,Chan DC.The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility.Nat Commun2017;8:15074 PMCID:PMC5413954

[59] Son J,Ying H,Hua S,Perera RM,Mullarky E,Kang Y,Bardeesy N,Haigis MC,Cantley LC.Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.Nature2013;496:101-5 PMCID:PMC3656466

[60] Figueroa ME,Lu C,Patel J,Li Y,Vasanthakumar A,Tallman MS,Wolniak K,Liu W,Fantin VR,Löwenberg B,Godley LA,Valk PJ,Levine RL.Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.Cancer Cell2010;18:553-67 PMCID:PMC4105845

[61] Ward PS,Wise DR,Bennett BD,Cross JR,Hedvat CV,Rabinowitz JD,Su SM,Levine RL.The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.Cancer Cell2010;17:225-34 PMCID:PMC2849316

[62] Letouzé E,Loriot C,Abermil N,Janin M,Nguyen AT,Buffet A,Bertherat J,Rustin P,Gimenez-Roqueplo AP.SDH mutations establish a hypermethylator phenotype in paraganglioma.Cancer Cell2013;23:739-52

[63] Xiao M,Xu W,Lin H,Liu L,Yang C,Zhao S,Xiong Y.Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.Genes Dev2012;26:1326-38 PMCID:PMC3387660

[64] Pan M,Lowman XH,Tran TQ,Yang Y,Rosales KK,Hugo W,Xu X,Ann DK,Lo RS,Kong M.Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation.Nat Cell Biol2016;18:1090-101 PMCID:PMC5536113

[65] van Geldermalsen M,Nagarajah R,Thoeng A,Ritchie W,Bailey CG,Harvey K,Selinger CI,Rasko JE.ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.Oncogene2016;35:3201-8 PMCID:PMC4914826

[66] Bröer A,Bröer S.Deletion of amino acid transporter ASCT2 (SLC1A5) reveals an essential role for transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to sustain glutaminolysis in cancer cells.J Biol Chem2016;291:13194-205 PMCID:PMC4933233

[67] Polletta L,Carnevale I,Rotili D,Steegborn C,Schutkowski M,Sansone L,Runci A,Morgante E,Mai A,Tafani M.SIRT5 regulation of ammonia-induced autophagy and mitophagy.Autophagy2015;11:253-70 PMCID:PMC4502726

[68] Masamha CP,Yang J,Li M,Li W.CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.Nature2014;510:412-6 PMCID:PMC4128630

[69] Redis RS,Lu W,Ivan C,Adamoski D,Taguchi A,Fernandez AF,Van Roosbroeck K,Shah M,Han L,Cheung LH,Monroig P,Catela Ivkovic T,Ling H,Kapitanovic S,Bankson JA,Lai SY,Rosenblum MG,Ivan M,Liang H,Widger WR,Berindan-Neagoe I,Ambrosio ALB,Calin GA.Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2.Mol Cell2016;61:520-34 PMCID:PMC4982398

[70] Colombo SL,Frakich N,Kovacs I,Moncada S.Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells.Proc Natl Acad Sci U S A2011;108:21069-74 PMCID:PMC3248543

[71] Fahien LA.Regulation of glutamate dehydrogenase by palmitoyl-coenzyme A.Arch Biochem Biophys1981;212:247-53

[72] Frieden C.Glutamate dehydrogenase. V. The relation of enzyme structure to the catalytic function.J Biol Chem1963;238:3286-99

[73] Tomita T,Nishiyama M.Structural basis for leucine-induced allosteric activation of glutamate dehydrogenase.J Biol Chem2011;286:37406-13 PMCID:PMC3199488

[74] Haigis MC,Haigis KM,Christodoulou DC,Valenzuela DM,Karow M,Wolberger C,Weindruch R,Guarente L.SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells.Cell2006;126:941-54

[75] Wang Y,Lu J,Wu D,Zheng Y.GLUL promotes cell proliferation in breast cancer.J Cell Biochem2017;118:2018-25

[76] van der Vos KE,Proikas-Cezanne T,van Boxtel R,van Zutphen IJ,Zellmer S,Verhagen LP,Braat AK,Holstege FC,Burgering BM.Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy.Nat Cell Biol2012;14:829-37

[77] Bott AJ,Fan Y,Zhao L,Neidler S,Jaber N,Lu W,Powers S,Hatzoglou M,Jones R,Girnun G.Oncogenic myc induces expression of glutamine synthetase through promoter demethylation.Cell Metab2015;22:1068-77 PMCID:PMC4670565

[78] Cox AG,Brown KK,Beltz S,O'Connor K,Yimlamai D,Yuan M,Wucherpfennig J,Minami A,Camargo FD,Houvras Y,Goessling W.Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth.Nat Cell Biol2016;18:886-96 PMCID:PMC4990146

[79] Arad G,Kulka RG.Glutamine-stimulated modification and degradation of glutamine synthetase in hepatoma tissue culture cells.Cell1976;8:95-101

[80] Demars R.The inhibition by glutamine of glutamyl transferase formation in cultures of human cells.Biochim Biophys Acta1958;27:435-6

[81] Nguyen TV,Sweredoski MJ,Jeon SJ,Yim JH,Handa H,Jeong JS,Park CS,Deshaies RJ.Glutamine triggers acetylation-dependent degradation of glutamine synthetase via the thalidomide receptor cereblon.Mol Cell2016;61:809-20 PMCID:PMC4889030

[82] Abu Aboud O,Trott J,Liang S,Sutcliffe J.Glutamine addiction in kidney cancer suppresses oxidative stress and can be exploited for real-time imaging.Cancer Res2017;77:6746-58

[83] Petronini PG,Alfieri R,Guidotti GG.Cell susceptibility to apoptosis by glutamine deprivation and rescue: survival and apoptotic death in cultured lymphoma-leukemia cell lines.J Cell Physiol1996;169:175-85

[84] Weinberg F,Wheaton WW,Joseph J,Kalyanaraman B,Budinger GR.Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.Proc Natl Acad Sci U S A2010;107:8788-93 PMCID:PMC2889315

[85] Tardito S,Ahmed SU,Keunen O,Miletic H,Weinstock A,Lindsay SL,Barnett SC,Mørkve SH,Chalmers AJ,Niclou SP.Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.Nat Cell Biol2015;17:1556-68 PMCID:PMC4663685

[86] Pavlova NN,Ghergurovich JM,Intlekofer AM,Rabinowitz JD,Zhang J.As extracellular glutamine levels decline, asparagine becomes an essential amino acid.Cell Metab2018;27:428-38

[87] Krall AS,Graeber TG,Christofk HR.Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor.Nat Commun2016;7:11457 PMCID:PMC4855534

[88] Durán RV,Robitaille AM,Skendaj R,Hall MN.Glutaminolysis activates Rag-mTORC1 signaling.Mol Cell2012;47:349-58

[89] Durán RV,Boulahbel H,Heiserich L,Bussolati O,Hall MN.HIF-independent role of prolyl hydroxylases in the cellular response to amino acids.Oncogene2013;32:4549-56 PMCID:PMC3787797

[90] Jewell JL,Russell RC,Park HW,Tagliabracci VS.Metabolism. Differential regulation of mTORC1 by leucine and glutamine.Science2015;347:194-8 PMCID:PMC4384888

[91] Tan HWS,Long YC.Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation.Nat Commun2017;8:338 PMCID:PMC5569045

[92] Villar VH,Delcroix V,Bouchecareilh M,Bodineau C,Priault M,Durán RV.mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation.Nat Commun2017;8:14124 PMCID:PMC5264013

[93] Csibi A,Li C,Choo AY,Jeong SM,Parkhitko A,Henske EP,Cantley LC,Yu J.The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.Cell2013;153:840-54 PMCID:PMC3684628

[94] Jeong SM,Finley LW,Souza AL,Li YH,Laurent G,Xu X,Wang RH,Csibi A,Blenis J,Kimmelman A,Haigis MC.SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism.Cancer Cell2013;23:450-63 PMCID:PMC3650305

[95] Csibi A,Yoon SO,Ilter D,Fendt SM,Blenis J.The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation.Curr Biol2014;24:2274-80 PMCID:PMC4190129

[96] Coloff JL,Braun CR,Shelton LM,Gygi SP,Brugge JS.Differential glutamate metabolism in proliferating and quiescent mammary epithelial cells.Cell Metab2016;23:867-80

[97] White MA,Rajapakshe K,Shi Y,Mukhopadhyay R,Dawood W,Frigo DE.Glutamine transporters are targets of multiple oncogenic signaling pathways in prostate cancer.Mol Cancer Res2017;15:1017-28 PMCID:PMC5685160

[98] Scalise M,Galluccio M.Glutamine transport. From energy supply to sensing and beyond.Biochim Biophys Acta2016;1857:1147-57

[99] Tanaka K,Irino Y,Nagashima H,Kyotani K,Imahori T,Masui K,Yang H,Sasaki R,Kohmura E.Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.J Clin Invest2015;125:1591-602 PMCID:PMC4396477

[100] Robinson MM,Tsukamoto T,Ferraris DV,Hansen JC.Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES).Biochem J2007;406:407-14 PMCID:PMC2049044

[101] Gross MI,Dennison JB,Chernov-Rogan T,Janes JR,Lewis ER,Mackinnon AL,Rodriguez ML,Sjogren EB,Wang T,Zhao F.Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.Mol Cancer Ther2014;13:890-901

[102] Jacque N,Larrue C,Birsen R,Saland E,Maciel TT,Poulain L,Sujobert P,Chapuis N,Moura IC,Sarry JE,Mayeux P,Bouscary D.Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.Blood2015;126:1346-56 PMCID:PMC4608389

[103] Korangath P,Sadik H,Mori N,Wildes F,Zhang Z,Tsai H,Stearns V,Sukumar S.Targeting glutamine metabolism in breast cancer with aminooxyacetate.Clin Cancer Res2015;21:3263-73 PMCID:PMC4696069

[104] Li M,Smith TJ.High throughput screening reveals several new classes of glutamate dehydrogenase inhibitors.Biochemistry2007;46:15089-102 PMCID:PMC2440342

[105] Qing G,Vu A,Walton ZE,Mayes PA,Thompson CB,Hogarty MD.ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation.Cancer Cell2012;22:631-44 PMCID:PMC3510660

[106] Cheng T,Yang C,Jin ES,DeBerardinis RJ.Pyruvate carboxylase is required for glutamine-independent growth of tumor cells.Proc Natl Acad Sci U S A2011;108:8674-9 PMCID:PMC3102381

[107] Christen S,Schmieder R,Metzger K,Elia I,Orth MF,Grünewald TG,Fendt SM.Breast cancer-derived lung metastases show increased pyruvate carboxylase-dependent anaplerosis.Cell Rep2016;17:837-48

[108] Linares JF,Duran A,Valencia T,Castilla EA,Metallo CM.ATF4-induced metabolic reprograming is a synthetic vulnerability of the p62-deficient tumor stroma.Cell Metab2017;26:817-29